secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001193125-23-076835
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical amends CEO James Corbett's employment agreement; severance extended, options vest on change of control
--------------------------------------------------------------------------------

- Annual bonus payout moved to no later than March 15 for prior calendar year.
- Option grants now provide 100% immediate vesting upon a Change in Control.
- Severance period increased from 12 to 18 months for termination without cause or for good reason.
- Removed change-in-control termination payments and long-distance commuting reimbursements for food/fuel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523076835/0001193125-23-076835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523076835/d804540d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-076835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer